Cloud-computing solutions and software enable researchers to garner insight from large, public-health datasets.
British Telecommunications (BT) and Accelrys are collaborating to provide solutions for analyzing massive datasets using BT for Life Sciences Cloud Compute Platform combined with Accelrys Enterprise Platform and Accelrys Pipeline Pilot software, the companies announced in a press release. The tools can be used to mine information on healthcare topics from very large datasets.
BT has collated publically available health system and social care information into a research repository intended for use by the life sciences and healthcare industries as well as academia, initially hosted in the United States and United Kingdom, but available for global access. Such data can provide valuable insight into a number of healthcare topics, such as disease prevalence, impact of ethnic mix and adverse drug reactions. However, the information is often contained in very large datasets and may be unstructured in nature. The datasets can be analyzed using the BT and Accelrys tools.
“The generation of ever-increasing amounts of health data is both a blessing and a curse, as they are data-rich, but often information-poor,” said Leif Pedersen, senior vice president of marketing, product management and corporate development at Accelrys, in the press release. “Working with BT, we’ve shown that we can deliver meaningful and valuable insights from these huge datasets.”
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.